Moderna /newsroom/taxonomy/term/15987/all en Â鶹´«Ã½ÍøÕ¾ and Moderna to expand collaborations with new projects in Lipid Nanoparticle research /newsroom/channels/news/mcgill-university-and-moderna-expand-collaborations-new-projects-lipid-nanoparticle-research-349107 <p>Â鶹´«Ã½ÍøÕ¾ today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.</p> Tue, 18 Jul 2023 13:25:38 +0000 claire.loewen@mcgill.ca 306289 at /newsroom Â鶹´«Ã½ÍøÕ¾ joins Moderna in battle against global health threats /newsroom/channels/news/mcgill-university-joins-moderna-battle-against-global-health-threats-338610 <p>Â鶹´«Ã½ÍøÕ¾ has joined Moderna’s <a href="https://mrna-access.modernatx.com/">mRNA Access</a> program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. Â鶹´«Ã½ÍøÕ¾ is the first university in Canada to join this program as it ramps up its international rollout.</p> Wed, 23 Mar 2022 21:04:28 +0000 shirley.cardenas@mcgill.ca 287084 at /newsroom